Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ·Healthcare·Biotechnology
$14.92
+6.72%
Mkt Cap $449.65M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (14 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+67.6%
Consensus $25.00 vs current $14.92